Development of a new safe method for preserving cells for medical treatments
Official title: Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery
Funded at Cryocrate, LLC · NIH-10823211 · Data updated 2026-11-12
This study is testing a new safe solution called OdinSol® that helps store cells and tissues for treatments like regenerative medicine, making sure they stay healthy and work better without harmful chemicals.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cryocrate, LLC NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $940,821 |
| NIH project number | 1R44OD035392-01A1 |
| Project ID | NIH-10823211 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals requiring cell-based therapies, such as those with age-related macular degeneration or other conditions needing regenerative treatments.
✕Less likely to help
Patients who do not require cell-based therapies or those with conditions not addressed by this technology may not benefit.
What this research studies
This research focuses on creating a biocompatible cryopreservation medium called OdinSol® that allows for the safe and efficient storage of cells and tissues used in regenerative medicine. By eliminating toxic substances commonly used in cryopreservation, this technology aims to enhance the viability and functionality of cell-based therapies. The project involves collaboration with various organizations to ensure the product meets regulatory standards and demonstrates superior performance compared to existing methods.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective cell-based therapies for patients.
How similar studies have gone: Previous research has shown promise in developing biocompatible cryopreservation methods, indicating potential for success in this novel approach.
Where this research is happening
-
Cryocrate, LLC
Columbia, United States Active
Researchers
- Principal investigator: Han, Xu — Cryocrate, LLC
- Study coordinator: Han, Xu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.